Research published in Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia

Randomized controlled trial of neurofeedback mindfulness meditation as a practice for migraine management.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia December 1, 2025 Faly Golshan, Gloria Sun, Jenna Francisco et al.

Recent studies indicate that mindfulness meditation may be beneficial for migraine symptoms; yet the potential of neurofeedback mindfulness meditation (NM) remains unexplored. This randomized controlled trial investigates the efficacy of NM compared to a controlled attention task for managing migraine. 101 adults with migraine participated in the study, wearing EEG headbands and engaging in...

DOI: 10.1016/j.jocn.2025.111685 Full text Mindfulness Headache Interoception Migraine disorders +2

Between sleep and wakefulness: how sleep quality and stress affect isolated sleep paralysis - a cross-sectional survey.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia September 1, 2025 Ahmed Ali Khan, Ammara Abid, Maheen Nawaz et al.

Sleep paralysis (SP) is a rapid-eye movement (REM) parasomnia in which a person is alert but temporarily unable to move or speak during the transition between wakefulness and sleep. It is a cardinal feature of narcolepsy; however, it may also occur independently as isolated sleep paralysis (ISP). This study examines ISP's prevalence, sociodemographic variations, and contributing factors,...

DOI: 10.1016/j.jocn.2025.111435 Full text Sleep paralysis Non-rapid eye movement Parasomnias

Intravenous ketamine infusions in patients with depression and Epilepsy: Case series.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia December 1, 2024 Mariusz Stanisław Wiglusz, Zuzanna Chmielewska, Wiesław Jerzy Cubała 1 citation

Mood disorders affect approximately one-third of individuals with epilepsy, posing an increased risk of suicide. There is an unquestionable need for more effective antidepressant treatment in this group of patients. This study explores the safety and tolerability of low-dose intravenous ketamine in six patients with comorbid depression and epilepsy. This report is limited to the post-hoc...

DOI: 10.1016/j.jocn.2024.110908 Full text Case report Intravenous #depression-treatment depression therapy Mood disorder treatment +6

Out-of-body experience in the anterior insular cortex during the intracranial electrodes stimulation in an epileptic child.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia August 1, 2018 Kaijia Yu, Chang Liu, Tao Yu et al.

The authors present a case of an out-of- body experience (OBE) that occurred in a child with intractable epilepsy when stimulating the anterior insular cortex (AIC) by intracranial electrodes. After destroying several sites precisely located at the left AIC by radiofrequency thermocoagulation, the patient's seizures disappeared, and the OBE could not be reproduced when repeatedly stimulating...

DOI: 10.1016/j.jocn.2018.04.050 Full text Consciousness Epilepsy Insular cortex Out-of-body experience +1

Buzz Juice: Neurological sequelae of synthetic cannabinoids.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia March 1, 2017 Manisha Kak, Fadi Mikhail, Sho T Yano et al.

The use of synthetic cannabinoids is becoming more widespread. Familiarity with the potential toxicities associated with these agents will grow in importance. We present a case of a woman who developed onset of confusion, visual hallucinations, and ataxia after vaporizing synthetic cannabinoids. MRI imaging demonstrated restricted diffusion and increased T2/FLAIR signal in the corpus callosum...

DOI: 10.1016/j.jocn.2016.10.046 Full text Buzz juice Corpus callosum Encephalopathy MRI +2

'Ecstasy'-induced subarachnoid haemorrhage: an under-reported neurological complication?

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia November 2003 Gabriel Yin Foo Lee, Grace Wooi Kee Gong, Nikitas Vrodos et al.

In the face of escalating recreational use of 'Ecstasy' (3,4-methylenedioxymethamphetamine, MDMA), physicians need to be aware of its possible adverse effects. We report two young patients who suffered subarachnoid haemorrhage following ingestion of 'Ecstasy' tablets. Angiographic studies demonstrated features consistent with vasculitis in both cases. Recognition of this association is...

DOI: 10.1016/s0967-5868(03)00151-6 Full text